ArticleBlood neoplasia2024

Impact of ibrutinib dose adjustment on TTNT in first-line CLL/SLL: a real-world analysis using target trial emulation.

Nilanjan Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.